Results 231 to 240 of about 2,034,935 (392)
In a population‐based cohort of 149 chronic myelomonocytic leukaemia (CMML) patients, multihit TET2 mutation was associated with older age, lower LDH and less leucocytosis. We found no association with autoimmune disease or thrombosis. Patients with multihit TET2 mutation had a significantly longer overall survival than the patients without or with one
Matilda Kjellander Kynning +14 more
wiley +1 more source
Zonulin levels in children with chronic immune thrombocytopenia. [PDF]
Karadoğan M +4 more
europepmc +1 more source
COVID-19 vaccination and immune thrombocytopenia
Allyson M. Pishko, J. Bussel, D. Cines
semanticscholar +1 more source
Rilzabrutinib in immune thrombocytopenia: a targeted, patient-centered alternative to conventional therapies. [PDF]
Afridi H +4 more
europepmc +1 more source
Summary Despite evidence‐based guidelines to inform platelet transfusion practice, unnecessary platelet transfusion persists. We performed a multicentre retrospective analysis of adults admitted to general medicine, subspecialty medicine and critical care from 1 January 2017 to 30 June 2022.
Sarah Ryan +14 more
wiley +1 more source
Immunomodulatory Mechanisms and Therapeutic Potential of Vitamin D in Immune Thrombocytopenia. [PDF]
Ma Y +9 more
europepmc +1 more source
Left panel: Scheme of the XPAG‐immune thrombocytopenia trial. The dexamethasone (DEX) arm consisted of DEX 40 mg/day for days 1–4 for one to three cycles every 28 days to a maximum of 12 weeks, cycles 2 + 3 were optional. Patients randomised to eltrombopag (ETB) + DEX received eltrombopag in combination with a short course of high‐dose DEX beginning on
Paul Schmidt‐Barbo +24 more
wiley +1 more source
IgG lymphocytotoxic antibodies in clinical liver transplantation: Studies toward further defining their significance [PDF]
Bronsther, S +10 more
core

